Guidant Ventak VR
This article was originally published in The Gray Sheet
Executive Summary
Implantable cardioverter defibrillator debuts in the U.S. following FDA market go-ahead May 6. The 51 cc ICD incorporates single-chamber, adaptive-rate pacing and will compete with Medtronic's 48 cc Gem SR ICD with single-chamber, adaptive-rate pacing. The Gem SR was approved in October 1998